secwatch.observer — SEC 8-K summary
======================================

Issuer:     LAVA Therapeutics NV (—)
CIK:        0001840748
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001104659-25-019127
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

LAVA Therapeutics receives Nasdaq deficiency notice; shares below $1.00 for 30 days
--------------------------------------------------------------------------------

- Nasdaq notified LAVA on Feb 27, 2025, that its common shares failed to meet the $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 days, until Aug 26, 2025, to regain compliance by closing at $1.00+ for 10 consecutive trading days.
- Failure could lead to transfer to Nasdaq Capital Market for an additional 180-day cure period if eligibility criteria are met.
- LAVA will monitor bid price and consider available options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840748/000110465925019127/0001104659-25-019127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840748/000110465925019127/tm257957d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-019127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer